Lambert Tim J, Singh Bruce S, Patel Maxine X
Discipline of Psychological Medicine, Brain and Mind Research Institute, University of Sydney, Camperdown, New South Wales, Australia.
Br J Psychiatry Suppl. 2009 Nov;52:S57-62. doi: 10.1192/bjp.195.52.s57.
The community treatment order (CTO) is the legal framework by which people in the community are compelled to accept treatment. Both antipsychotic long-acting injections (LAIs) and CTOs are used to address treatment non-adherence.
To investigate the relationship between CTOs and LAI use in patients with schizophrenia.
Prescribing, demographic and CTO data were collected for patients from four community mental health clinics in Melbourne, Australia, in 1998 and 2002.
Against a background of increasing use of oral second-generation antipsychotic (SGA) medication and decreasing use of LAIs, the rates of CTO implementation doubled from 13% to 26% of patients with schizophrenia between 1998 and 2002. Proportionally more patients with a CTO are prescribed LAIs rather than oral SGAs.
The relationship between receiving an LAI and being subject to a CTO is significant, and reflects the consideration given to enhancing adherence in a community mental health setting.
社区治疗令（CTO）是一种法律框架，通过该框架可强制社区中的人接受治疗。抗精神病长效注射剂（LAIs）和社区治疗令均用于解决治疗不依从问题。
调查精神分裂症患者中社区治疗令与长效注射剂使用之间的关系。
收集了1998年和2002年澳大利亚墨尔本四家社区心理健康诊所患者的处方、人口统计学和社区治疗令数据。
在口服第二代抗精神病药物（SGA）使用增加而长效注射剂使用减少的背景下，1998年至2002年间，精神分裂症患者中社区治疗令的实施率从13%翻了一番至26%。接受社区治疗令的患者中，按比例更多的人使用长效注射剂而非口服第二代抗精神病药物。
接受长效注射剂与接受社区治疗令之间的关系显著，这反映了在社区心理健康环境中对提高依从性的考虑。
